CBD may increase THC exposure, raising interaction concerns
Does co-administration of cannabidiol (CBD) influence the plasma availability of delta-9-tetrahydrocannabinol (THC) and its active metabolite in humans? A systematic review and meta-analysis.
AI Summary
A systematic review and meta-analysis examined whether taking CBD alongside THC changes how much THC and its active metabolite, 11-hydroxy-THC (11-OH-THC), circulate in the blood. The review included 14 studies involving 341 participants, covering oral, inhaled, and intravenous administration. Because the studies produced mixed results, the researchers combined their findings using random-effects meta-analysis.
On average, co-administering CBD was linked to a significantly higher overall exposure to THC over time, although the certainty of this evidence was very low. Exposure to 11-OH-THC was also higher, and its peak blood concentration increased; both findings had medium-certainty evidence. The analysis further suggested that the CBD dose affected the peak concentration and overall exposure of 11-OH-THC, but not measured THC levels. These results indicate a potential pharmacokinetic interaction, so cannabis users and clinicians should be alert to possible differences when combining CBD and THC.
💡 Key Findings
📄
Original Abstract
Related Research
Similar Studies
More THC research papers you might find interesting.
Small lab study finds cannabis affected simulated driving and confidence
A lab method measures 17 cannabinoids across five hemp product types
A single-center study finds varied care and no recurrence in follow-up
Explore More Research
Stay informed about the latest cannabis science.